Oral Vasodilator Protocol among Advanced Decompensated Heart Failure Patients Managed with Intravenous Vasodilator Therapy
نویسندگان
چکیده
منابع مشابه
Vasodilator therapy for decompensated heart failure.
odium nitroprusside is appropriate for the acute treatment f congestive heart failure. The starting dose is 0.3 to 0.5 g/kg/min titrated to goal attainment of desired hemodyamics but usually not beyond 5 g/kg/min. Doses of 10 g/kg/min or sustained administration will result in excesive cyanide production, which may occasionally lead to yanide poisoning and may rarely lead to the development f m...
متن کاملAcute vasodilator therapy increases renal clearance of digoxin in patients with congestive heart failure.
We studied the effect of vasodilator therapy on renal digoxin clearance in patients with chronic congestive heart failure. Intravenous administration of nitroprusside or hydralazine to eight patients with severe heart failure produced the expected increase in cardiac output and a decrease in central circulatory pressure. Renal clearance of sodium para-aminohippurate and estimated renal blood fl...
متن کاملParadoxical hypertension after reversal of heart failure in patients treated with intensive vasodilator therapy.
Hypertension is a major cause of heart failure, evolving from left ventricular hypertrophy to systolic and diastolic dysfunction. Although effective heart failure therapy has been associated with a lowering or no change in systemic arterial blood pressure in long-term follow-up, this study describes the symptomatic, clinical, and left ventricular functional response of a subgroup of heart failu...
متن کاملUse and impact of inotropes and vasodilator therapy in hospitalized patients with severe heart failure.
BACKGROUND Treatment of decompensated heart failure often includes the use of intravenous vasoactive medications, but the effect on outcome has not been clearly defined. METHODS Data from 433 patients enrolled in the ESCAPE trial were analyzed to determine 6-month risks of all-cause mortality and all-cause mortality plus rehospitalization associated with the use of vasodilators, inotropes, an...
متن کاملVasodilator therapy for chronic left ventricular failure.
The effects of chronic oral vasodilator therapy were studied in a group of patients with refractory congestive heart failure. Fifteen patients were treated acutely with intravenous sodium nitroprusside and sublingual isosorbide dinitrate. After continuous therapy with nitroprusside and isosorbide dinitrate for up to 72 hours the patients were then placed on isosorbide dinitrate and oral phenoxy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cardiac Failure
سال: 2018
ISSN: 1071-9164
DOI: 10.1016/j.cardfail.2018.07.125